Molecular Characterization of Soft Tissue Sarcomas Using RNA-Based Next-Generation Sequencing
International Journal of Molecular Sciences · 16.03.2026 · 27 (6) · 2699
DOI: 10.3390/ijms27062699 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.03.2026. Verfasst von Bogdan Serban und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics and Traumatology, University Emergency Hospital, 050098 Bucharest, Romania. Hauptthemen laut MEDLINE: Sarcoma, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Social Fund+ (ESF+) of European Union.
Abstract (Originalsprache)
Soft tissue sarcomas are rare malignant mesenchymal tumors for which accurate diagnosis, prognostic stratification, and therapeutic decision-making remain challenging. Although histopathology and immunohistochemistry are essential diagnostic tools, they frequently fail to capture the molecular complexity underlying tumor aggressiveness and treatment resistance. In this study, we evaluated the utility of RNA-based next-generation sequencing for the molecular characterization of STS and for elucidating transcriptomic mechanisms associated with aggressive tumor behavior. An observational cohort of 24 patients with histologically confirmed soft tissue sarcomas was analyzed, using adipose and skeletal muscle tissue as controls. RNA was extracted from tumor samples, libraries were prepared with a targeted pan-cancer panel, and sequencing was performed on the Illumina platform, followed by bioinformatic analysis using DRAGEN pipelines and DESeq2. RNA-NGS identified a predominance of single-nucleotide polymorphisms and significant differential gene expression, with overexpression of proliferation-related genes (TOP2A, MKI67, BUB1B), extracellular matrix and microenvironment-associated genes (COL11A1, SPP1), and developmental regulators (HOXD13, MELK). Subgroup analysis revealed a distinct transcriptomic profile in leiomyosarcoma, while gene fusion analysis detected clinically relevant alterations. These findings demonstrate that RNA-NGS provides biologically and clinically meaningful insights into the molecular landscape of soft tissue sarcomas and supports its integration into precision medicine-oriented diagnostic workflows.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics and Traumatology, University Emergency Hospital, 050098 Bucharest, Romania.
- Orthopedics and Traumatology Department, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Molecular Biology and Pathology Research Laboratory, University Emergency Hospital, 050098 Bucharest, Romania.
ORCID-Profile: Adrian Cursaru, Bogdan Cretu, Eugen Radu
Förderung
- European Social Fund+ (ESF+) of European Union
Zitieren
APA
Serban, B., Cursaru, A., Iordache, S., Cretu, B., Nica, M., Iacobescu, G., Popa, M., Radu, E., Cirnu, M., & Cirstoiu, C. (2026). Molecular Characterization of Soft Tissue Sarcomas Using RNA-Based Next-Generation Sequencing. International Journal of Molecular Sciences, 27(6), 2699. https://doi.org/10.3390/ijms27062699
Vancouver
Serban B, Cursaru A, Iordache S, Cretu B, Nica M, Iacobescu G, et al. Molecular Characterization of Soft Tissue Sarcomas Using RNA-Based Next-Generation Sequencing. International Journal of Molecular Sciences. 2026;27(6):2699. doi:10.3390/ijms27062699
BibTeX
@article{Serban2026,
author = {Serban, Bogdan and Cursaru, Adrian and Iordache, Sergiu and Cretu, Bogdan and Nica, Mihai and Iacobescu, Georgian and Popa, Mihnea and Radu, Eugen and Cirnu, Madalina and Cirstoiu, Catalin},
title = {Molecular Characterization of Soft Tissue Sarcomas Using RNA-Based Next-Generation Sequencing},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {6},
pages = {2699},
doi = {10.3390/ijms27062699}
}
EUVIMED